COMMUNIQUÉS West-GlobeNewswire

Universe Pharmaceuticals INC Receives Staff Determination Notice from Nasdaq Related to Delayed Annual Report

25/02/2025 - 22:10

Ji’an, Jiangxi, China, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that on February 19, 2025, the [...]

Allogene Therapeutics Expands Strategic Partnership with Foresight Diagnostics to Advance Joint Development Activities Outside the US Across Europe, UK, Canada, and Australia

25/02/2025 - 22:10

SOUTH SAN FRANCISCO, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T ™ ) products [...]

ORIC® Pharmaceuticals Announces Focused Registrational Clinical Development Plans for Lead Programs, Extended Cash Runway, and Updated Corporate Milestones

25/02/2025 - 22:15

Anticipated registrational development plans for ORIC-944 and ORIC-114 prioritized to focus on indications with strongest clinical validation and highest unmet need ORIC-944 initiation of first Phase 3 trial in mCRPC [...]

Ardelyx to Participate in Upcoming Investor Conferences

25/02/2025 - 22:15

WALTHAM, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet [...]

Jasper Therapeutics to Present at Upcoming March Investor Conferences

25/02/2025 - 22:30

REDWOOD CITY, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting [...]

Coherus Management to Participate at the 45th Annual TD Cowen Health Care Conference

24/02/2025 - 15:08

REDWOOD CITY, Calif., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus,” NASDAQ: CHRS) today announced that senior management will participate in a fireside chat presentation at the 45th Annual TD [...]

Bright Green Corporation Announces the completion of its restructuring plan, withdraws from the Cannabis business and sets course on the production of all DEA Scheduled Controlled Substances

24/02/2025 - 15:15

FORT LAUDERDALE, FLORIDA, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Bright Green Corporation (OTC: BGXX) (“Bright Green” or the “Company”) announced that on February 24, 2025, on behalf of the Company, Lynn Stockwell has asked [...]

WW International, Inc. Schedules Fourth Quarter and Full Year 2024 Earnings Conference Call

24/02/2025 - 15:15

NEW YORK, Feb. 24, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) will release its results for the fourth quarter and full year 2024 ended December 28, 2024, [...]

SYNERGIA MEDICAL ANNOUNCES STRONG RESULTS FOR NAO.VNS™ FIRST-IN-HUMAN STUDY

24/02/2025 - 15:30

Primary safety endpoint met - No serious adverse events reported over 3-months Robust device performance - No device failure reported over 3-months Synergia Medical announces that its NAO.VNS™ device, successfully [...]

OrganOx Completes $142 Million Equity Financing Led by HealthQuest Capital

24/02/2025 - 16:10

Financing strengthens OrganOx to expand its leadership position in organ technology OXFORD, United Kingdom and MADISON, N.J., Feb. 24, 2025 (GLOBE NEWSWIRE) -- OrganOx Ltd ., a leading organ medical technology company, [...]

United States FDA Approves NM8074 (Ruxoprubart) IND for Treating Dermatomyositis (DM): A Chronic Inflammatory Disorder of the Skin

24/02/2025 - 16:11

--- The United States FDA Approves the Initiation for Phase II Efficacy Trial in Dermatomyositis ( DM ) Patients: A Skin & Muscle Disorder DM is an immune-mediated myopathy characterized by chronic inflammation of [...]

Harvard Bioscience Schedules Fourth Quarter 2024 Earnings Conference Call for March 12, 2025 at 8:00 AM ET

24/02/2025 - 17:00

HOLLISTON, Mass., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended December 31, 2024, before the market opens on March 12, 2025, and [...]

Compass Health announces the Marc Healing Center as name of state-of-the-art regional facility for intensive behavioral health services

24/02/2025 - 17:46

The Marc Healing Center is Phase II of Compass Health’s three-phase Broadway Campus Redevelopment, designed to advance whole person health in Northwest Washington EVERETT, Wash., Feb. 24, 2025 (GLOBE NEWSWIRE) -- On [...]

SRx Health Solutions Shareholders Unanimously Approve Acquisition by Better Choice Company

24/02/2025 - 19:52

TAMPA, Fla., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE American: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, announced today that SRx Health Solutions, Inc. (“ [...]

AEON Biopharma, Inc. Announces Reverse Stock Split

24/02/2025 - 20:00

IRVINE, Calif., Feb. 24, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (NYSE: AEON) (the “Company”), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex under a 351(k) biosimilar [...]

Latest DB-OTO Results Demonstrate Clinically Meaningful Hearing Improvements in Nearly All Children with Profound Genetic Hearing Loss in CHORD Trial

24/02/2025 - 21:00

As presented at ARO, 10 of 11 children with at least one post-treatment assessment showed notable improvements in hearing Speech and development progress followed dramatic improvements in hearing in first child treated [...]

Galapagos to Present at Upcoming Investor Conferences

24/02/2025 - 22:01

Mechelen, Belgium; February 24, 2025, 22:01 CET – Galapagos NV (Euronext & NASDAQ: GLPG), a global biotechnology company dedicated to transforming patient outcomes through life-changing science and innovation, today [...]

Ascendis Pharma to Participate in the TD Cowen 45th Annual Health Care Conference

24/02/2025 - 22:01

COPENHAGEN, Denmark, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that company executives will participate in a fireside chat at the TD Cowen 45th Annual Health Care Conference on [...]

Mersana Therapeutics to Host Fourth Quarter and Year End 2024 Conference Call on March 3, 2025

24/02/2025 - 22:01

CAMBRIDGE, Mass., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates ( [...]